Veracyte [VCYT] vs Charles River [CRL] Detailed Stock Comparison
Veracyte
NASDAQ
Loading...
Charles River
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Veracyte wins in 8 metrics, Charles River wins in 11 metrics, with 0 ties. Charles River appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Veracyte | Charles River | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 105.88 | 681.33 | Veracyte |
| Price-to-Book Ratio | 2.32 | 2.60 | Veracyte |
| Debt-to-Equity Ratio | 4.15 | 82.04 | Veracyte |
| PEG Ratio | -0.93 | -17.28 | Charles River |
| EV/EBITDA | 40.17 | 11.91 | Charles River |
| Profit Margin (TTM) | 5.50% | -1.66% | Veracyte |
| Operating Margin (TTM) | 11.00% | 16.67% | Charles River |
| EBITDA Margin (TTM) | 11.00% | 16.67% | Charles River |
| Return on Equity | 2.24% | -1.81% | Veracyte |
| Return on Assets (TTM) | 1.98% | 4.31% | Charles River |
| Free Cash Flow (TTM) | $63.81M | $501.61M | Charles River |
| 1-Year Return | 5.94% | -9.34% | Veracyte |
| Price-to-Sales Ratio (TTM) | 5.91 | 2.17 | Charles River |
| Enterprise Value | $2.56B | $11.38B | Charles River |
| EV/Revenue Ratio | 5.35 | 2.83 | Charles River |
| Gross Profit Margin (TTM) | 68.97% | 34.59% | Veracyte |
| Revenue per Share (TTM) | $6 | $80 | Charles River |
| Earnings per Share (Diluted) | $0.34 | $-1.30 | Veracyte |
| Beta (Stock Volatility) | 2.12 | 1.50 | Charles River |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Veracyte vs Charles River Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Veracyte | 0.11% | 7.23% | 11.03% | 36.83% | 22.05% | -10.88% |
| Charles River | -1.34% | 19.02% | 7.99% | 13.68% | 30.49% | -4.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Veracyte | 5.94% | 130.88% | -15.83% | 452.76% | 193.01% | 193.01% |
| Charles River | -9.34% | -11.29% | -27.19% | 164.92% | 429.35% | 312.72% |
News Based Sentiment: Veracyte vs Charles River
Veracyte
News based Sentiment: MIXED
October was a month of contrasts for Veracyte, marked by significant insider selling alongside positive stock performance and optimistic analyst ratings. While the insider activity warrants attention, the overall narrative suggests a company with growth potential facing both opportunities and risks.
Charles River
News based Sentiment: POSITIVE
The month of October saw a continuation of positive momentum for Charles River Laboratories, driven by multiple analyst upgrades and increased price targets following a strong Q2 earnings report. While some insider selling and mixed institutional activity exist, the overall narrative is one of growing optimism and potential for further growth.
Performance & Financial Health Analysis: Veracyte vs Charles River
| Metric | VCYT | CRL |
|---|---|---|
| Market Information | ||
| Market Cap | $2.83B | $8.82B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 894,093 | 1,082,057 |
| 90 Day Avg. Volume | 967,581 | 919,842 |
| Last Close | $36.04 | $174.95 |
| 52 Week Range | $22.61 - $47.32 | $91.86 - $230.02 |
| % from 52W High | -23.83% | -23.94% |
| All-Time High | $86.03 (Feb 08, 2021) | $460.21 (Sep 20, 2021) |
| % from All-Time High | -58.11% | -61.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.01% |
| Quarterly Earnings Growth | 0.14% | -0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | -0.02% |
| Operating Margin (TTM) | 0.11% | 0.17% |
| Return on Equity (TTM) | 0.02% | -0.02% |
| Debt to Equity (MRQ) | 4.15 | 82.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.54 | $68.14 |
| Cash per Share (MRQ) | $4.08 | $3.72 |
| Operating Cash Flow (TTM) | $93.45M | $787.45M |
| Levered Free Cash Flow (TTM) | $75.40M | $706.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Veracyte vs Charles River
| Metric | VCYT | CRL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 105.88 | 681.33 |
| Forward P/E | 90.00 | 17.25 |
| PEG Ratio | -0.93 | -17.28 |
| Price to Sales (TTM) | 5.91 | 2.17 |
| Price to Book (MRQ) | 2.32 | 2.60 |
| Market Capitalization | ||
| Market Capitalization | $2.83B | $8.82B |
| Enterprise Value | $2.56B | $11.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.35 | 2.83 |
| Enterprise to EBITDA | 40.17 | 11.91 |
| Risk & Other Metrics | ||
| Beta | 2.12 | 1.50 |
| Book Value per Share (MRQ) | $15.54 | $68.14 |
Financial Statements Comparison: Veracyte vs Charles River
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VCYT | CRL |
|---|---|---|
| Revenue/Sales | $114.47M | $984.17M |
| Cost of Goods Sold | $34.97M | $666.44M |
| Gross Profit | $79.51M | $317.73M |
| Research & Development | $17.72M | N/A |
| Operating Income (EBIT) | $1.16M | $74.67M |
| EBITDA | $3.03M | $184.23M |
| Pre-Tax Income | $7.43M | $35.98M |
| Income Tax | $381,000 | $10.10M |
| Net Income (Profit) | $7.05M | $25.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VCYT | CRL |
|---|---|---|
| Cash & Equivalents | $186.12M | $229.36M |
| Total Current Assets | $383.15M | $1.51B |
| Total Current Liabilities | $75.13M | $1.05B |
| Long-Term Debt | $43.09M | $2.99B |
| Total Shareholders Equity | $1.19B | $3.24B |
| Retained Earnings | $-436.94M | $1.84B |
| Property, Plant & Equipment | $70.15M | $402.91M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VCYT | CRL |
|---|---|---|
| Operating Cash Flow | $18.76M | $130.09M |
| Capital Expenditures | $-1.82M | N/A |
| Free Cash Flow | $3.54M | $112.37M |
| Debt Repayment | N/A | $-149.39M |
| Common Stock Repurchase | N/A | $-353.13M |
Short Interest & Institutional Ownership Analysis
| Metric | VCYT | CRL |
|---|---|---|
| Shares Short | 9.13M | 2.56M |
| Short Ratio | 9.44 | 3.38 |
| Short % of Float | 0.13% | 0.06% |
| Average Daily Volume (10 Day) | 894,093 | 1,082,057 |
| Average Daily Volume (90 Day) | 967,581 | 919,842 |
| Shares Outstanding | 77.77M | 51.14M |
| Float Shares | 78.21M | 48.62M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.09% | 1.06% |
Dividend Analysis & Yield Comparison: Veracyte vs Charles River
| Metric | VCYT | CRL |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |